Futureco Bioscience Company Profile

Background

Overview

Futureco Bioscience, established in 1993 and headquartered in Olèrdola, Barcelona, Spain, is an agro-biotechnology company specializing in the research, development, manufacture, and global commercialization of environmentally friendly products for crop protection and nutrition. The company is present in over 40 countries, offering biopesticides and biostimulants to farmers worldwide.

Mission and Vision

Futureco Bioscience's mission is to lead the transition to regenerative agriculture by creating value through scientific knowledge and technological innovation. The company aims to provide innovative and sustainable solutions that enhance crop yields while minimizing environmental impact.

Primary Area of Focus

The company's primary focus is on developing biotechnological products that promote sustainable agriculture. This includes biopesticides for pest control and biostimulants that enhance plant growth and resilience.

Industry Significance

Futureco Bioscience plays a significant role in the agro-biotechnology industry by offering eco-friendly alternatives to traditional chemical pesticides and fertilizers. Its products contribute to sustainable farming practices and support global efforts to reduce the environmental footprint of agriculture.

Key Strategic Focus

Core Objectives

• Develop and commercialize innovative biotechnological products for sustainable agriculture.

• Expand global presence through strategic partnerships and subsidiaries.

• Enhance research and development capabilities to drive product innovation.

Specific Areas of Specialization

• Biopesticides: Products designed to control pests and diseases in crops.

• Biostimulants: Products that enhance plant growth, resilience, and yield.

• Biofertilizers: Products that improve soil health and nutrient availability.

Key Technologies Utilized

• Microbial agents: Utilized in biopesticides and biostimulants.

• Natural extracts: Incorporated into product formulations for enhanced efficacy.

• Advanced research methodologies: Employed in the development of new products.

Primary Markets Targeted

• Latin America: Including countries like Mexico, Peru, Colombia, Costa Rica, and Brazil.

• Europe: With a focus on Spain and other European nations.

• Asia: Targeting markets such as Turkey and China.

Financials and Funding

Funding History

Futureco Bioscience is a privately held company, and detailed financial information is not publicly disclosed.

Recent Funding Rounds

• Peru Expansion (2023): Received a €300,000 loan from COFIDES to support growth in the Peruvian market.

• Mexico Expansion (2024): Secured a €300,000 loan from COFIDES to strengthen its presence in Mexico.

Notable Investors

Specific details about individual investors are not publicly available.

Utilization of Capital

The funds are primarily used to:

• Establish and expand subsidiaries in target markets.

• Develop and commercialize new biotechnological products.

• Enhance research and development capabilities.

Pipeline Development

Key Pipeline Candidates

• Nofly: A bioinsecticide registered for controlling whiteflies in various regions, including Europe, the USA, and Mexico.

• Bestcure: A biofungicide registered for controlling diseases like Botrytis, Alternaria, and Xanthomonas in countries such as South Africa, Colombia, and Peru.

Stages of Development

• Nofly: Registered and commercially available in multiple markets.

• Bestcure: Registered and available in select markets; expansion ongoing.

Target Conditions

• Nofly: Whitefly infestations in various crops.

• Bestcure: Fungal and bacterial diseases in a range of crops.

Anticipated Milestones

• Expansion of product registrations into additional countries.

• Introduction of new biotechnological products to address emerging agricultural challenges.

Technological Platform and Innovation

Proprietary Technologies

• Microbial Strains: A collection of over 3,000 fungi and bacteria used in biocontrol and biostimulant products.

• Metabolite Identification: Identification of organic compounds from microbial origin with potential biocontrol or biostimulant activity.

Significant Scientific Methods

• In Vitro Bioassays: Conducting over 1,500 annual tests to evaluate microbial efficacy.

• In Vivo Bioassays: Performing approximately 300 annual field trials to validate product effectiveness.

Leadership Team

Key Executives

• Rafael Juncosa: President and CEO. Oversees global operations and strategic direction.

• Javier Honrado: Finance Director. Manages financial strategies and investments.

• Clevis Castellón: Area Manager for Costa Rica and the Caribbean. Leads regional operations and market expansion.

Competitor Profile

Market Insights and Dynamics

The global market for biostimulants and biopesticides is experiencing significant growth, driven by increasing demand for sustainable agricultural practices and environmentally friendly crop protection solutions. Key regions include Europe, North America, and Latin America.

Competitor Analysis

• Key Competitors: Companies such as Syngenta, BASF, and Bayer are prominent in the biopesticide and biostimulant sectors.

• Competitive Landscape: The market is characterized by innovation, regulatory compliance, and the ability to scale operations globally.

Strategic Collaborations and Partnerships

Significant Collaborations

• Sumitomo Corporation (2025): Entered a global agreement to co-develop and commercialize innovative biological crop protection technologies.

Strategic Opportunities and Future Directions

• Expansion into New Markets: Establishing subsidiaries in regions like Turkey and China to tap into emerging agricultural markets.

• Product Innovation: Developing new biotechnological products to address evolving agricultural challenges.

Contact Information

Official Website

www.futurecobioscience.com

Social Media Profiles

• LinkedIn: Futureco Bioscience LinkedIn profile

• Twitter: @FuturecoBio

• Facebook: Futureco Bioscience Facebook page